Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Bo Zhou

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Acta Pharmacologica Sinica|June 14, 2023
Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathwayHan-Lin Wang, Jia-Nan Li, Wei-Juan Kan, et al.
Acta Pharmacologica Sinica|August 4, 2023
Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibitionKai-Long Jiang, Chang-Mei Liu, Li-Tong Nie, et al.
Acta Pharmacologica Sinica|August 29, 2020
Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphomaXiao-Tuan Zhang, Xiao-Bei Hu, Han-Lin Wang, et al.
Acta Pharmacologica Sinica|August 3, 2021
Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myelomaYu-Bo Zhou, Yang-Ming Zhang, Hong-Hui Huang, et al.
Acta Pharmacologica Sinica|March 30, 2021
Downregulation of c-Myc expression confers sensitivity to CHK1 inhibitors in hematologic malignanciesKai-Long Jiang, Le-Xian Tong, Tao Wang, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Acta Pharmacologica Sinica|June 14, 2023
Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathwayHan-Lin Wang, Jia-Nan Li, Wei-Juan Kan, et al.
Acta Pharmacologica Sinica|August 4, 2023
Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibitionKai-Long Jiang, Chang-Mei Liu, Li-Tong Nie, et al.
Acta Pharmacologica Sinica|August 29, 2020
Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphomaXiao-Tuan Zhang, Xiao-Bei Hu, Han-Lin Wang, et al.
Acta Pharmacologica Sinica|August 3, 2021
Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myelomaYu-Bo Zhou, Yang-Ming Zhang, Hong-Hui Huang, et al.
Acta Pharmacologica Sinica|March 30, 2021
Downregulation of c-Myc expression confers sensitivity to CHK1 inhibitors in hematologic malignanciesKai-Long Jiang, Le-Xian Tong, Tao Wang, et al.
Pageof 11